Sinonasal Acinic Cell Carcinoma: A Review of the National Cancer Database

Am J Rhinol Allergy. 2022 Nov;36(6):741-746. doi: 10.1177/19458924221107206. Epub 2022 Jun 14.

Abstract

Background: Acinic cell carcinoma (ACC) is a salivary gland malignancy that rarely can involve the sinonasal cavity. There are limited outcomes data available to guide management.

Objective: We sought to use the National Cancer Database (NCDB) to characterize treatment outcomes in sinonasal ACC.

Methods: A retrospective analysis of the NCDB from 2004 to 2016 for patients with ACC involving the sinonasal cavity was conducted. Demographic, treatment, and survival information were obtained. Unadjusted Kaplan-Meier estimates, log-rank tests, and a multivariable Cox proportional hazard model were used to assess overall survival (OS).

Results: A total of 28 patients were included in the analysis with an average age of 58.6 ± 15.5 years. Half the patients (n = 14, 50%) were male, mostly white (n = 23, 82.1%), and with private insurance (n = 16, 57.1%). The nasal cavity was the most common subsite (n = 18, 64.3%), followed by the maxillary sinus (n = 5, 17.9%). Most patient received surgery alone (n = 17, 60.7%), with the remaining patients undergoing surgery followed by radiation (n = 8, 28.6%), radiation alone (n = 1, 3.6%), and no treatment (n = 2, 7.1%). The 1-, 5-, and 10-year survival in this cohort was 100% (95% CI: 100%-100%), 84.3% (95% CI: 71.2%-99.7%), and 72.2% (95% CI: 55%-94.8%), respectively. On multivariate analysis, older age was associated with worse OS (hazard ratio (HR): 1.27; 95% CI: 1.11-1.46, P < .001). Disease of the sphenoid sinus correlated with worse survival (HR: 198, 95% CI: 10.4-3,739, P < .001) and large tumor size was associated with worse OS on log-rank test, but not on multivariate analysis.

Conclusion: Sinonasal ACC is a rare entity with relatively good long-term outcomes. Older age and primary disease of the sphenoid sinus are associated with worse outcomes. Most patients are treated with surgical resection. Future research is needed to assess the optimal timing and indications for radiation therapy.

Keywords: NCDB; National Cancer Database; acinar cell; acinic cell; cancer; outcomes; sinonasal; sinus; skull base; survival.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Acinar Cell* / epidemiology
  • Carcinoma, Acinar Cell* / therapy
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Paranasal Sinus Neoplasms* / epidemiology
  • Paranasal Sinus Neoplasms* / therapy
  • Proportional Hazards Models
  • Retrospective Studies